Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A wild strawberry plant in a greenhouse

Jun 9, 2026

Is Redwire (RDW) Using Space Greenhouses To Reframe Its Life Sciences Growth Story?

Redwire Corporation is making strides in the life sciences sector by leveraging its Greenhouse systems on the International Space Station (ISS) to cultivate wild strawberries and test a proprietary biostimulant from Astrobiome Space. This initiative marks a significant milestone as it represents the first commercial space greenhouse, showcasing Redwire's ambition to expand into space-enabled agriculture.This development signals a shift for Redwire from traditional government contracts to innovat
A clipboard with a checkmark in a dark monochromatic style.

Jun 9, 2026

Quantified Launches New AI Sales Coaching Platform to Transform How Life Sciences Teams Prepare, Coach, and Win

Quantified has launched an innovative AI Sales Coaching Platform aimed at enhancing the readiness and performance of life sciences commercial teams. This platform expands upon its existing AI Roleplay solution, integrating Adaptive AI and various coaching capabilities to support representatives throughout their entire lifecycle.The newly introduced platform is designed to improve critical metrics such as rep readiness, message adherence, and field execution. It utilizes Adaptive AI to tailor coa
A stack of clinical data records in a research facility

Jun 9, 2026

Tempus AI Presents Asymmetric Upside From Data Moat

Tempus AI is garnering attention for its potential growth, bolstered by a unique clinical data advantage and increasing collaborations with pharmaceutical companies.According to a recent analysis by Seeking Alpha, the company reported impressive financial results for Q1 2026, with Diagnostics revenue reaching $261 million and a gross margin of 62.3%. Additionally, its Data and Applications segment saw a year-over-year growth of approximately 41%, achieving a margin of 73.1%. Tempus AI boasts a s
minimalist representation of a small molecule

Jun 9, 2026

Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Evogene Ltd. is set to showcase its advancements in drug discovery at the upcoming BIO International Convention, scheduled for June 22-25, 2026, in San Diego, California.The company, known for its innovative work in computational chemistry and AI-driven design of small molecules, will highlight its recent breakthroughs in pharmaceutical applications. Ofer Haviv, the CEO, along with Dr. Gabi Tarcic and Dr. Olga Nissan, will represent Evogene at the event. Dr. Tarcic is expected to present on the
A vial of Jelmyto on a lab countertop

Jun 9, 2026

How Resolving Jelmyto Patent Litigation And Setting 2030 Generic Entry At UroGen Pharma (URGN) Has Changed Its Investment Story

UroGen Pharma's recent settlement with Teva Pharmaceuticals over its Jelmyto patent marks a pivotal moment for the company, establishing a timeline for generic competition that could reshape its investment landscape.In June 2026, UroGen Pharma reached a settlement allowing Teva to produce a generic version of Jelmyto starting September 15, 2030, contingent upon FDA approval. This agreement alleviates some legal uncertainties surrounding UroGen’s urothelial cancer treatment and sets a clear path
A minimalist illustration of a pill symbolizing pharmaceutical research.

Jun 9, 2026

Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner

The pharmaceutical industry's increasing reliance on China for research and development is reshaping global drug innovation, with over $43 billion in licensing agreements made in just five months of 2026. This shift marks a significant realignment in how and where pharmaceutical companies source innovative solutions.Major players like AstraZeneca, Bristol Myers Squibb, and Pfizer have made substantial commitments to Chinese firms, signaling a strategic pivot rather than isolated transactions. As
A banana peel on a desk with coins, symbolizing financial loss.

Jun 9, 2026

Insider Buyers At aTyr Pharma Likely Disappointed With 19% Slide

The recent 19% decline in aTyr Pharma, Inc.'s stock is likely disappointing for insiders who had invested approximately $911.8k at an average price of $0.91 per share in the past year. As a result of this drop, their investment is now valued at only $442.1k, significantly diminishing their initial stake.Over the last year, insider Paul Schimmel made the most substantial purchase, acquiring shares worth $912k at $0.94 each. This indicates a belief in the company's potential, especially since the
A minimalist illustration of a linear accelerator in a hospital setting.

Jun 9, 2026

Dr L H Hiranandani Hospital Expands Cancer Care with Smart Hospital Infrastructure

Dr. L H Hiranandani Hospital in Mumbai has significantly enhanced its cancer care capabilities with the launch of a second Advanced Radiation Therapy Unit and an innovative Pneumatic Chute System.This expansion is a collaborative effort with the International Oncology Cancer Institute and aims to streamline hospital operations through advanced technology. The new Advanced Radiation Therapy Unit utilizes the Halcyon High-End Linear Accelerator, which allows for precise radiation delivery while mi
An office desk with scattered banknotes and a pen, symbolizing recent financial activity in quantum technology investment.

Jun 9, 2026

Four quantum companies raised $961M in seven days. Europe wrote the checks.

In a remarkable week for quantum computing, four companies in Europe collectively raised $961 million, signaling a significant shift in investment dynamics within the sector.During this period, Oxford Quantum Circuits and another Oxford-based firm, OQC, each secured $350 million in Series C funding, marking a historic moment for private investment in European quantum technology. IQM, a Finnish company, increased its PIPE funding to $146 million as it prepares for a dual listing on Nasdaq and Nas
Flat illustration of an AI chip

Jun 9, 2026

Intel jumps 11% as Google names it AI chip manufacturer; ASML surges on Musk Terafab catalyst, SOXX +5.9%

Intel's stock surged by over 11% following Google's announcement to purchase 3 million AI chips, marking a significant recovery for the semiconductor company.Intel Corp. experienced its largest single-day gain in more than a year, closing at $110.27. This spike follows Google's commitment to contract Intel for the production of approximately 3 million custom AI accelerators, which is one of the largest third-party foundry deals in Intel's history. Additionally, Intel has formed strategic partner

Jun 8, 2026

DATAN Analytics AI+ Sets To Transform Clinical Trial Operations: Interview With Dr. Franziska Eidloth

SAP drafting in hours instead of days. SAS code generated in minutes. As the FDA and EMA issue their first joint guidance on AI in submissions, DATAN Analytics is already deploying agents in real clinical workflows. We spoke with Dr. Franziska Eidloth about what this shift means — and what it demands from biostatisticians.SAP generation automated from days to hours — an 80% reduction in a task that is central to every clinical trialThe FDA and EMA have issued joint guidance on AI in submissions,
Flat design of a stack of coins representing investment

Jun 8, 2026

Venture Capital for German Biotech Firms Collapsed in 2025

Venture capital funding for German biotech firms faced a significant downturn in 2025, marking a notable shift in the European life sciences landscape. This contraction followed a period of robust investment driven by pandemic-related innovations and advancements in oncology and mRNA technologies.The decline in funding can be attributed to a broader reassessment of risk among investors, influenced by rising interest rates and a shift toward shorter-duration investments. Unlike software startups,